CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+18.68%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$432M
AUM Growth
+$432M
(+14%)
Cap. Flow
+$50.7M
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
72.69%
Holding
32
New
3
Increased
10
Reduced
2
Closed
7
Top Buys
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$25.2M |
| 2 |
Merus
MRUS
|
$24.8M |
| 3 |
Xenon Pharmaceuticals
XENE
|
$16M |
| 4 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$11.9M |
| 5 |
Protagonist Therapeutics
PTGX
|
$10.5M |
Top Sells
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$26.1M |
| 2 |
Kura Oncology
KURA
|
$18.7M |
| 3 |
Celldex Therapeutics
CLDX
|
$13.4M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$8.95M |
| 5 |
Revolution Medicines
RVMD
|
$6.22M |
Sector Composition
| 1 | Healthcare | 99.43% |
| 2 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Astria Therapeutics
ATXS
$349M
| – | – |
-239,270
| Closed | -$2.12M |
|
|
27
Celldex Therapeutics
CLDX
$1.47B
| – | – |
-248,207
| Closed | -$13.4M |
|
|
28
Iovance Biotherapeutics
IOVA
$807M
| – | – |
-362,869
| Closed | -$8.95M |
|
|
29
Kura Oncology
KURA
$686M
| – | – |
-999,433
| Closed | -$18.7M |
|
|
30
Revolution Medicines
RVMD
$7.1B
| – | – |
-226,228
| Closed | -$6.22M |
|
31
ARS Pharmaceuticals
SPRY
$1.15B
| – | – |
-97,143
| Closed | -$969K |
|
|
DRNA
32
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-1,292,251
| Closed | -$26.1M |
|